← Leaderboards
Brenda Diergaarde
University Of Pittsburgh At Pittsburgh
$4,504,466
Attributed
$4,504,466
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.2M · FY2010–14$2M$1.5M$1M$500K$0
'10
'11
'12
'13
'14
Funding mix
By agency
NIH$4,504,466 · 1
By mechanism
P50$4,504,466 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Pittsburgh At Pittsburgh
Same institution · by research overlap
- Jennifer R Grandis$109,711,044
- Jill M Siegfried$10,296,579
- Patricia Lynn Opresko$15,295,285
- John Munn Kirkwood$15,450,309
- Rajiv Dhir$8,351,145
Others in their field
Top investigators on “Detection”
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Francis L Halzen · University Of Wisconsin-Madison$243,423,219
- Robert B Gagosian · Consortium For Ocean Leadership, Inc$232,495,072
- Richard A Gibbs · Baylor College Of Medicine$209,716,260
- Richard K. Wilson · Washington University$206,265,868
- Craig B Thompson · Sloan-Kettering Inst Can Research$156,512,301
Research focus
DetectionBaseBiologicalAlcohol ConsumptionCancer EtiologyCandidate Disease GeneCarcinogensCase-Control StudiesCcnd1 GeneAlcoholsCell CycleCell Cycle RegulationCessation Of LifeChemopreventionChemotherapeutic AgentChemotherapyClinicCohort StudiesComplexCustomCytotoxicCdc GenesDesignDisease Outcome
Grant awards (5)
Pathway and GWAS SNPs: Role in SCCHN Risk, Outcome and Treatment Response$958,011
P50 · FY2014 · CA · contact PI
Pathway and GWAS SNPs: Role in SCCHN Risk, Outcome and Treatment Response$330,109
P50 · FY2013 · CA · contact PI
Pathway and GWAS SNPs: Role in SCCHN Risk, Outcome and Treatment Response$1,021,889
P50 · FY2012 · CA · contact PI
Pathway and GWAS SNPs: Role in SCCHN Risk, Outcome and Treatment Response$1,038,578
P50 · FY2011 · CA · contact PI
Pathway and GWAS SNPs: Role in SCCHN Risk, Outcome and Treatment Response$1,155,879
P50 · FY2010 · CA · contact PI